Over 90 Total Lots Up For Auction at One Location - WA 04/08

Canon Medical’s Alphenix Platform at the forefront of helping hospitals prepare for the future of interventional medicine

Press releases may be edited for formatting or style | December 05, 2019 Alzheimers/Neurology Operating Room
CHICAGO--(BUSINESS WIRE)--Since its launch in 2018, Canon Medical’s Alphenix™ platform has helped clinicians think beyond the traditional boundaries of interventional procedures, with its streamlined workflow, dose optimization and improved image resolutions. For example, the specialized team of neuroendovascular surgeons at Kaleida Health Gates Vascular Institute, a leading international stroke and cardiac care facility in Buffalo, N.Y., have successfully utilized the platform’s biplane technology with the world’s first High-Definition Flat Panel Detector to advance neurovascular treatment options for patients. This innovative technology enables clinicians to see fine details clearly and precisely during complex interventional procedures, enabling them to prioritize workflow, clinical insight and patient care.

“The high-definition imaging capabilities are most beneficial during the critical stage when we are utilizing high magnification imagery to deploy a complex intravascular device such as stents, coils, flow diverters and endovascular flow disruptors,” said Adnan Siddiqui, MD, PhD, director of neurological stroke services at Gates Vascular Institute and associate professor of neurosurgery at the University at Buffalo. “There’s nothing that comes close to the ability to visualize these implements than with Canon Medical’s high-definition technology.”

Canon Medical’s Hi-Def Detector, available on the Alphenix Biplane and Alphenix Core + systems, is the world’s first high-definition detector for resolving fine details.

“By enabling the visualization of intricate anatomy with the highest level of resolution available* in the angiography market, our Hi-Def Detector offers clinicians the ability to perform minimally invasive neurovascular therapy with clear images to see fine details, enabling them to prioritize clinical decisions and patient outcomes,” said Kristin Jones, acting managing director, Vascular Business Unit, Canon Medical Systems USA, Inc. “The Alphenix platform is an example of Canon Medical’s commitment to providing next generation technology that our customers need to treat their patients safely, accurately and confidently.”

Canon Medical is showcasing the Alphenix family of products and Alphenix Hi-Def Detector technology at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, December 1 – 6, 2019 (Booth #1933, South Level 3).


About Canon Medical Systems USA, Inc.

You Must Be Logged In To Post A Comment